UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PKR involvement in Alzheimer's disease

Alzheimer's research & therapy, 2017-10, Vol.9 (1), p.83-83, Article 83

2017

Volltextzugriff (PDF)

Ketogenic diet therapy in Alzheimer's disease: an updated review

Current opinion in clinical nutrition and metabolic care, 2021-07, Vol.24 (4), p.372-378

2021

Volltextzugriff (PDF)

From dysfunctional endoplasmic reticulum-mitochondria coupling to neurodegeneration

Neurochemistry international, 2017-10, Vol.109, p.171-183

2017

Volltextzugriff (PDF)

Efficacy and Safety of Ketone Supplementation or Ketogenic Diets for Alzheimer's Disease: A Mini Review

Frontiers in nutrition (Lausanne), 2022-01, Vol.8, p.807970-807970

2022

Volltextzugriff (PDF)

Blood-Based Kinase Assessments in Alzheimer's Disease

Frontiers in aging neuroscience, 2018-11, Vol.10, p.338-338

2018

Volltextzugriff (PDF)

Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20‐dependent negative feedback loop

Glia, 2018-08, Vol.66 (8), p.1736-1751

2018

Volltextzugriff (PDF)

Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer’s disease

NeuroImage clinical, 2024-01, Vol.43, p.103626, Article 103626

2024

Volltextzugriff (PDF)

PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca2+/Calmodulin-Dependent kinase II-δ activation in mouse models of down syndrome

Journal of comparative neurology (1911), 2011-10, Vol.519 (14), p.2779-2802

2011

Volltextzugriff (PDF)

The PKR Activator PACT Is Induced by Aβ: Involvement in Alzheimer's Disease

Brain pathology (Zurich, Switzerland), 2012-03, Vol.22 (2), p.219-229

2012

Volltextzugriff (PDF)

Modulation of oxidative stress and tau phosphorylation by the mTOR activator phosphatidic acid in SH-SY5Y cells

FEBS letters, 2011-06, Vol.585 (12), p.1801-1806

2011

Volltextzugriff (PDF)

Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway

Biochimica et biophysica acta, 2012-06, Vol.1822 (6), p.885-896

2012

Volltextzugriff (PDF)

Downregulated apoptosis and autophagy after anti‐Aβ immunotherapy in Alzheimer's disease

Brain pathology (Zurich, Switzerland), 2018-09, Vol.28 (5), p.603-610

2018

Volltextzugriff (PDF)

STAT3 inhibition protects against neuroinflammation and BACE1 upregulation induced by systemic inflammation

Immunology letters, 2020-12, Vol.228, p.129-134

2020

Volltextzugriff (PDF)

Are ketogenic diets promising for Alzheimer's disease? A translational review

Alzheimer's research & therapy, 2020-04, Vol.12 (1), p.42-42, Article 42

2020

Volltextzugriff (PDF)

PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions

Aging cell, 2019-06, Vol.18 (3), p.e12887-n/a

2019

Volltextzugriff (PDF)

Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study

Neurobiology of disease, 2023-01, Vol.176, p.105937-105937, Article 105937

2023

Volltextzugriff (PDF)

The role of adiponectin in Alzheimer’s disease: A translational review

The Journal of nutrition, health & aging, 2024-03, Vol.28 (3), p.100166-100166, Article 100166

2024

Volltextzugriff (PDF)

PCP4 (PEP19) overexpression induces premature neuronal differentiation associated With Ca2+/Calmodulin-dependent kinase II-δ activation in mouse models of down syndrome

Journal of comparative neurology (1911), 2011-12, Vol.519 (17), p.3597-3597

2011

Volltextzugriff (PDF)

Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study

Alzheimer's research & therapy, 2022-05, Vol.14 (1), p.71-71, Article 71

2022

Volltextzugriff (PDF)

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice

International journal of molecular sciences, 2022-11, Vol.23 (21), p.13488

2022

Volltextzugriff (PDF)

Modulation of Tau Phosphorylation by the Kinase PKR: Implications in Alzheimer's Disease

Brain pathology (Zurich, Switzerland), 2011-03, Vol.21 (2), p.189-200

2011

Volltextzugriff (PDF)

Dual Kinase Inhibition Affords Extended in vitro Neuroprotection in Amyloid-β Toxicity

Journal of Alzheimer's disease, 2016-10, Vol.54 (4), p.1659-1670

2016

Volltextzugriff (PDF)

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer's disease

Alzheimer's research & therapy, 2020-07, Vol.12 (1), p.88-88, Article 88

2020

Volltextzugriff (PDF)

Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline

Journal of psychiatry & neuroscience, 2015-05, Vol.40 (3), p.151-161

2015

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(127)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PKR involvement in Alzheimer's disease

Phosphorylation of Parkin at serine 65 is essential for its activation in vivo

Ketogenic diet therapy in Alzheimer's disease: an updated review

From dysfunctional endoplasmic reticulum-mitochondria coupling to neurodegeneration

Efficacy and Safety of Ketone Supplementation or Ketogenic Diets for Alzheimer's Disease: A Mini Review

Blood-Based Kinase Assessments in Alzheimer's Disease

Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20‐dependent negative feedback loop

Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer’s disease

PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca2+/Calmodulin-Dependent kinase II-δ activation in mouse models of down syndrome

The PKR Activator PACT Is Induced by Aβ: Involvement in Alzheimer's Disease

Modulation of oxidative stress and tau phosphorylation by the mTOR activator phosphatidic acid in SH-SY5Y cells

Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway

Downregulated apoptosis and autophagy after anti‐Aβ immunotherapy in Alzheimer's disease

STAT3 inhibition protects against neuroinflammation and BACE1 upregulation induced by systemic inflammation

Are ketogenic diets promising for Alzheimer's disease? A translational review

PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions

Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study

The role of adiponectin in Alzheimer’s disease: A translational review

PCP4 (PEP19) overexpression induces premature neuronal differentiation associated With Ca2+/Calmodulin-dependent kinase II-δ activation in mouse models of down syndrome

Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice

Modulation of Tau Phosphorylation by the Kinase PKR: Implications in Alzheimer's Disease

Dual Kinase Inhibition Affords Extended in vitro Neuroprotection in Amyloid-β Toxicity

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer's disease

Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline

Suchergebnisse filtern